基于网络药理学研究板蓝根抑菌活性成分及其作用机制

doi:10.11843/j.issn.0366-6964.2022.08.035

摘要/Abstract

摘要： 旨在基于网络药理学研究板蓝根的主要抑菌药效成分及其作用机理。利用中药系统药理学在线分析数据库（TCMSP）筛选出板蓝根药效成分及其潜在作用靶点，通过OMIM和GeneCards数据库以“抑菌”为关键词搜索相关靶点。通过Venny平台获取板蓝根和抑菌的交集靶点。通过STRING数据库结合Cytoscape软件构建PPI网络图并筛选关键靶点。通过DAVID数据库进行GO功能富集和KEGG通路富集分析。通过Autodock Tools 1.5.7软件将关键药效成分和抑菌靶点进行分子对接。通过菌落计数法和SDS-PAGE法验证关键药效成分抑菌作用和作用靶点。结果显示：共筛选到药效成分33个，药物靶点61个，抑菌靶点2 192个，药物与抑菌作用交集靶点32个。蛋白互作网络分析发现，TNF、TP53、CASP3、JUN、ESR1、PTGS2等30个蛋白可能是板蓝根抑菌作用的关键靶点。GO功能富集分析得到126个条目，包括生物过程条目86个（如对雌二醇的反应、凋亡信号通路、神经元凋亡过程的正调控），细胞组分条目11个（如细胞质、核），分子功能条目29个（如蛋白质同源二聚化活性、酶结合）。KEGG通路富集分析得到20条通路。分子对接结果显示，度值排名前3位的活性成分（β-谷甾醇、豆甾醇、金合欢素）与关键抑菌靶点编码蛋白的结合能均<0 kJ·mol^-1。抑菌试验验证表明，豆甾醇是板蓝根的关键药效成分，其能够下调胞内CASP3和PTGS2蛋白的表达。板蓝根主要通过药效成分豆甾醇作用于PTGS2、CASP3靶点，通过TNF、癌症途径信号通路发挥抑菌作用。

关键词: 板蓝根, 网络药理学, 抑菌活性, 作用机制

Abstract: The main antibacterial active ingredients and mechanism of Isatis indigotica were predicted based on network pharmacology. The active ingredients and targets of Isatis indigotica were screened by using TCMSP database; The related targets were searched by OMIM and GeneCards databases with the keyword of "antibacterial"; The intersection target of Isatis indigotica and bacteriostasis were collected through the Venny platform; STRING database combined with Cytoscape software were used to construct the PPI network and screen the key targets; GO function enrichment analysis and KEGG pathway enrichment analysis were carried out by using DAVID database; The key pharmacodynamic ingredients with the antibacterial targets were connected through Autodock Tools 1.5.7 software; The bacteriostatic effects against Escherichia coli(CVCC1515) and targets of the key ingredients were verified by colony counting and SDS-PAGE. A total of 33 active components of Isatis indigotica, 61 potential drug targets, 2 192 bacteriostatic targets, and 32 intersection targets of Isatis indigotica and bacteriostatic action were screened. Protein interaction network analysis revealed that 30 proteins, including TNF, TP53, CASP3, JUN, ESR1 and PTGS2 and so on, might be the key targets of antibacterial activity of Isatis indigotica. The GO functional enrichment analysis yielded 126 entries, including 86 biological process items (e.g. response to estradiol apoptotic signaling pathway, positive regulation of neuron apoptotic process), 11 cell composition items (e.g. cytoplasm, nucleus), and 29 molecular function items (e.g protein homodimerization activity, enzyme binding). KEGG pathway enrichment analysis yielded 20 related signal pathways. Molecular docking result showed that the binding energies of the key active components (beta-sitosterol, stigmasterol and acacetin) with the coding proteins of key antibacterial targets were all less than 0 kJ·mol^-1. Antibacterial experiments showed that stigmasterol was the key active component of Isatis indigotica which might down-regulated the expression of intracellular CASP3 and PTGS2 proteins. Stigmasterol of the active components of Isatis indigotica exerts antibacterial effect through the targets of CASP3 and PTGS2 which involved in TNF signaling pathway and pathways in cancer.

Key words: Isatis indigotica, network pharmacology, antibacterial activity, mechanism

中图分类号:

S853.74

田薇, 李秀梅, 杨娟, 王小莹, 周炜炜, 李中媛, 戴小枫. 基于网络药理学研究板蓝根抑菌活性成分及其作用机制[J]. 畜牧兽医学报, 2022, 53(8): 2782-2793.

TIAN Wei, LI Xiumei, YANG Juan, WANG Xiaoying, ZHOU Weiwei, LI Zhongyuan, DAI Xiaofeng. Network Pharmacology Study on the Antibacterial Activity Components and Mechanism of Isatis indigotica[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(8): 2782-2793.

参考文献 32

[1]	CHEN C C, LI J Y, ZHANG H X, et al. Effects of a probiotic on the growth performance, intestinal flora, and immune function of chicks infected with Salmonella pullorum[J]. Poult Sci, 2020, 99(11):5316-5323.
[2]	张仕泓, 王少林. 动物源产气荚膜梭菌耐药性研究进展[J]. 畜牧兽医学报, 2021, 52(10):2762-2771.ZHANG S H, WANG S L. Research progress on antimicrobial resistance of Clostridium perfringens of animal origins[J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(10):2762-2771. (in Chinese)
[3]	马毅敏, 李娜, 刘承伟, 等. 板蓝根不同提取部位抗炎镇痛活性比较研究[J]. 中草药, 2014, 45(17):2517-2521.MA Y M, LI N, LIU C W, et al. Comparative studies on anti-inflammatory and analgesic activities of different fractions from Isatidis radix[J]. Chinese Traditional and Herbal Drugs, 2014, 45(17):2517-2521. (in Chinese)
[4]	郑汝, 梁锦丽. 板蓝根不同提取部位抗菌活性的实验性研究[J]. 海峡药学, 2010, 22(4):32-34.ZHENG R, LIANG J L. Experimental study on the antibacterial activity of different extracts from Radix isatis[J]. Strait Pharmaceutical Journal, 2010, 22(4):32-34. (in Chinese)
[5]	冯永智, 徐永康, 牟嘉林. 常见中草药对大肠杆菌抑制效果研究现状[J]. 吉林畜牧兽医, 2020, 41(3):75, 77.FENG Y Z, XU Y K, MU J L. Research status of common Chinese herbal medicine's inhibitory effect on Escherichia coli[J]. Jilin Animal Husbandry and Veterinary Medicine, 2020, 41(3):75, 77. (in Chinese)
[6]	杨元娟, 杨元梅, 夏之宁. 板蓝根注射液抗菌活性的研究[J]. 中国医药指南, 2008, 6(10):19-21.YANG Y J, YANG Y M, XIA Z N. Study on the antibacterial activity of Radix isatidis injection[J]. Guide of Chinese Medicine, 2008, 6(10):19-21. (in Chinese)
[7]	张彦琼, 李梢. 网络药理学与中医药现代研究的若干进展[J]. 中国药理学与毒理学杂志, 2015, 29(6):883-892.ZHANG Y Q, LI S. Progress in network pharmacology for modern research of traditional Chinese medicine[J]. Chinese Journal of Pharmacology and Toxicology, 2015, 29(6):883-892. (in Chinese)
[8]	WANG L, ZHOU G B, LIU P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia[J]. Proc Natl Acad Sci U S A, 2008, 105(12):4826-4831.
[9]	XU G Y, LV X, FENG Y B, et al. Study on the effect of active components of Schisandra chinensis on liver injury and its mechanisms in mice based on network pharmacology[J]. Eur J Pharmacol, 2021, 910:174442.
[10]	张子越. 马齿苋水煎液体外抑制大肠杆菌和痢疾杆菌的作用机制的研究[D]. 泰安:山东农业大学, 2020.ZHANG Z Y. Study on the mechanism of purslane decoction in inhibiting E. coli and dysenteryn in vitro[D]. Taian:Shandong Agricultural University, 2020. (in Chinese)
[11]	彭爱红. 板蓝根药理活性成分及临床应用进展[J]. 中国当代医药, 2010, 17(12):13-14.PENG A H. The pharmacologically active components of Radix isatidis and its clinical application progress[J]. China Modern Medicine, 2010, 17(12):13-14. (in Chinese)
[12]	文开新, 王成章, 严学兵, 等. 黄酮类化合物生物学活性研究进展[J]. 草业科学, 2010, 27(6):115-122.WEN K X, WANG C Z, YAN X B, et al. Research progress of flavonoids biological activity[J]. Pratacultural Science, 2010, 27(6):115-122. (in Chinese)
[13]	BI C W, DONG X Y, ZHONG X B, et al. Acacetin protects mice from Staphylococcus aureus bloodstream infection by inhibiting the activity of Sortase A[J]. Molecules, 2016, 21(10):1285.
[14]	陈春林, 王健, 戈悦欣, 等. 高车前素药理作用研究进展[J]. 宜春学院学报, 2019, 41(12):17-20.CHEN C L, WANG J, GE Y X, et al. Research progress on pharmacological actions of hispidulin[J]. Journal of Yichun University, 2019, 41(12):17-20. (in Chinese)
[15]	陈慧敏, 戴岳, 夏玉凤. 生物碱类化合物与药物相互作用的研究现状[J]. 中国临床药理学杂志, 2021, 37(18):2523-2526.CHEN H M, DAI Y, XIA Y F. Research status of the interaction between alkaloids and drugs[J]. The Chinese Journal of Clinical Pharmacology, 2021, 37(18):2523-2526. (in Chinese)
[16]	陈元堃, 曾奥, 罗振辉, 等. β-谷甾醇药理作用研究进展[J]. 广东药科大学学报, 2021, 37(1):148-153.CHEN Y K, ZENG A, LUO Z H, et al. Advances on pharmacology of β-sitosterol[J]. Journal of Guangdong Pharmaceutical University, 2021, 37(1):148-153. (in Chinese)
[17]	ODODO M M, CHOUDHURY M K, DEKEBO A H. Structure elucidation of β-sitosterol with antibacterial activity from the root bark of Malva parviflora[J]. Springerplus, 2016, 5(1):1210.
[18]	漆亚云, 胡伟男, 孟娇, 等. 吲哚类化合物抑菌活性研究进展[J]. 化学研究与应用, 2019, 31(7):1225-1233.QI Y Y, HU W N, MENG J, et al. Research advance on antibacterial activity of indole compounds[J]. Chemical Research and Application, 2019, 31(7):1225-1233. (in Chinese)
[19]	MONTFORT A, COLACIOS C, LEVADE T, et al. The TNF paradox in cancer progression and immunotherapy[J]. Front Immunol, 2019, 10:1818.
[20]	KROESEN S, WIDMER A F, TYNDALL A, et al. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy[J]. Rheumatology (Oxford), 2003, 42(5):617-621.
[21]	PETITJEAN A, ACHATZ M I W, BORRESEN-DALE A L, et al. TP53 mutations in human cancers:functional selection and impact on cancer prognosis and outcomes[J]. Oncogene, 2007, 26(15):2157-2165.
[22]	GUDKOV A V, KOMAROVA E A. p53 and the carcinogenicity of chronic inflammation[J]. Cold Spring Harb Perspect Med, 2016, 6(11):a026161.
[23]	王媛, 白贵斌, 王娟, 等. p53信号通路在MTB感染肺泡Ⅱ型上皮细胞系A549中的免疫调控作用[J]. 西北农林科技大学学报:自然科学版, 2019, 47(8):8-16.WANG Y, BAI G B, WANG J, et al. Effect of p53 signaling pathway on AEC Ⅱ line A549 infected with Mycobacterium tuberculosis (MTB)[J]. Journal of Northwest A&F University:Natural Science Edition, 2019, 47(8):8-16. (in Chinese)
[24]	LAUNAY O, ROSENBERG A R, REY D, et al. Long-term immune response to hepatitis B virus vaccination regimens in adults with human immunodeficiency virus 1:secondary analysis of a randomized clinical trial[J]. JAMA Intern Med, 2016, 176(5):603-610.
[25]	PARK Y, HONG H, JANG B. Transcriptional and translational regulation of COX-2 expression by cadmium in C6 glioma cells[J]. Int J Mol Med, 2012, 30(4):960-966.
[26]	TORREY H, BUTTERWORTH J, MERA T, et al. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs[J]. Sci Signal, 2017, 10(462):eaaf8608.
[27]	YIN Q Y, ZHAO B, QIU Y Y, et al. Research progress of mechanisms and drug therapy for atherosclerosis on toll-like receptor pathway[J]. J Cardiovasc Pharmacol, 2019, 74(5):379-388.
[28]	苏鑫, 宫晓燕. 新扶正除疫颗粒对金葡球菌所致急性上呼吸道感染小鼠肺组织 TNF-α、IL-6含量的影响研究[J]. 时珍国医国药, 2016, 27(2):315-316.SU X, GONG X Y. The effect of Xinfuzheng Chuye Granules on the content of TNF-α and IL-6 in lung tissue of mice with acute upper respiratory tract infection caused by Staphylococcus aureus[J]. Lishizhen Medicine and Materia Medica Research, 2016, 27(2):315-316. (in Chinese)
[29]	WU W D, LI L P, LIU Y, et al. Multiomics analyses reveal that NOD-like signaling pathway plays an important role against Streptococcus agalactiae in the spleen of tilapia[J]. Fish Shellfish Immunol, 2019, 95:336-348.
[30]	MARTÍNEZ I, OLIVEROS J C, CUESTA I, et al. Apoptosis, toll-like, RIG-I-like and NOD-like receptors are pathways jointly induced by diverse respiratory bacterial and viral pathogens[J]. Front Microbiol, 2017, 8:276.
[31]	WATANABE T, KITANI A, MURRAY P J, et al. NOD2 is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses[J]. Nat Immunol, 2004, 5(8):800-808.
[32]	车蕾. 高氧液抑制根管内常见致病菌的实验研究[D]. 西安:中国人民解放军空军军医大学, 2018.CHE L. Experimental study of hyperoxia solution on the inhibition of common pathogenic bacteria in root canal[D]. Xi'an:Air Force Medical University, 2018. (in Chinese)